Catalyst Wire Dossier Catalyst Wire Dossier

NovoPen 4

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NovoPen 4, covering 2016-11-23 to 2016-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

See pricing